Role of tumour necrosis factor-α (TNFα) in the functional properties of hyalocytes

British Journal of Ophthalmology

Volumn 95, Issue 2, 2011, Pages 261-265

  Hata, Yasuaki ^a   Nakao, Shintaro ^a   Kohno, Ri Ichiro ^a   Oba, Kumiyo ^a   Kita, Takeshi ^a   Miura, Muneki ^a   Sassa, Yukio ^a   Schering, Alexander ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; CYTOKINE; DEXAMETHASONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STEROID; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HYALOCYTE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA CELL; VITREORETINOPATHY; VITREOUS BODY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CATTLE; CELL MIGRATION ASSAYS; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; MACROPHAGES; RECOMBINANT PROTEINS; RETINAL DISEASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VITREOUS BODY;

EID: 79151482940     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.190322     Document Type: Article

References (24)

1. Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS One 2009;4:e8158.
2. Kita T, Hata Y, Kano K, et al. Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor. Diabetes 2007;56:231-8. (Pubitemid 46263122)
3. Noda Y, Hata Y, Hisatomi T, et al. Functional properties of hyalocytes under PDGF-rich conditions. Invest Ophthalmol Vis Sci 2004;45:2107-14.
4. Demircan N, Safran BG, Soylu M, et al. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 2006;20:1366-9.
5. Armstrong D, Augustin AJ, Spengler R, et al. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 1998;212:410-14.
6. Shi X, Semkova I, Muther PS, et al. Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res 2006;83:1325-34.
7. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefes Arch Clin Exp Ophthalmol 2004;242:409-13.
8. Tanihara H, Yoshida M, Yoshimura N. Tumor necrosis factor-alpha gene is expressed in stimulated retinal pigment epithelial cells in culture. Biochem Biophys Res Commun 1992;187:1029-34.
9. Nakao S, Kuwano T, Ishibashi T, et al. Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins. J Immunol 2003;170:5704-11.
10. Lindstedt EW, Baarsma GS, Kuijpers RW, et al. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005;89:533-6.
11. Hamburg A. Some investigations on the cells of the vitreous body. Ophthalmologica 1959;138:81-107.
12. Sakamoto T. [Cell biology of hyalocytes]. Nippon Ganka Gakkai Zasshi 2003;107:866-82.
13. Qiao H, Hisatomi T, Sonoda KH, et al. The characterisation of hyalocytes: the origin, phenotype and turnover. Br J Ophthalmol 2005;89:513-17.
14. Haddad A, Andre JC. Hyalocyte-like cells are more numerous in the posterior chamber than they are in the vitreous of the rabbit eye. Exp Eye Res 1998;66:709-18.
15. Kohno RI, Hata Y, Kawahara S, et al. Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol 2009;93:1020-6.
16. Kawahara S, Hata Y, Kita T, et al. Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins. Diabetes 2008;57:2784-93.
17. Kita T, Hata Y, Arita R, et al. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Proc Natl Acad Sci U S A 2008;105:17504-9.
18. Hirayama K, Hata Y, Noda Y, et al. The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes. Invest Ophthalmol Vis Sci 2004;45:3896-903.
19. Sonoda KH, Enaida H, Ueno A, et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 2003;87:1010-14. (Pubitemid 36936302)
20. Enaida H, Hata Y, Ueno A, et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 2003;23:764-70.
21. Hata Y, Sassa Y, Kita T, et al. Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid. Br J Ophthalmol 2008;92:1540-4.
22. Miura M, Hata Y, Hirayama K, et al. Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells. Exp Eye Res 2006;82:849-59.
23. Becker M, Davis J. Vitrectomy in the treatment of uveitis. Am J Ophthalmol 2005;140:1096-105.
24. Harbour JW, Smiddy WE, Flynn HW Jr, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996;121:405-13.